Location: Home
  • search
  • go
  • Relate News
  • 5/15/2025Novartis Gains NMPA Approval for Expanded Use of Kisqali in Early Brea...
  • 5/15/2025NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...
  • 5/15/2025Hengrui Aims to Raise $1.27B in Hong Kong IPO
  • 5/14/2025NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M
  • 5/14/2025BRL Medicine's Allogeneic CAR-T Therapy Shows Promising Results in Ref...
  • 5/14/2025Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...
  • 5/14/2025RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...
  • 5/14/2025CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...
  • 5/14/2025Beigene Submits New Indication Application for BCL2 Inhibitor Sonrotoc...
  • 5/14/2025Six Drugs Granted Priority Review as China Registers Over 1,100 Produc...
  • 5/14/2025R&D Spending Rises at 276 Chinese Drugmakers Despite Revenue Pressures
  • 5/14/2025CDE Issues the List of Reference Formulations for GQCE Studies (92nd B...
  • 5/14/2025Chinese Drugmakers May Weather Trump's Tariff Threats With Cost Edge, ...
  • 5/13/2025China Expands Geriatric Services at Major Hospitals as Elderly Populat...
  • 5/12/2025Lepu's Miracogen Launches Phase 3 Trial of Novel EGFR-Targeting ADC Co...
  • 5/12/2025AusperBio Reports Promising Phase IIb Results for AHB-137 in Chronic H...
  • 5/12/2025CureGene Unveils Potent Liver-Targeted THR-β Prodrug CG-0416 with Pro...
  • 5/12/2025CARsgen Reports Encouraging Early Data for Allogeneic BCMA CAR-T CT059...
  • 5/12/2025China Biopharma Financing Drops in April 2025, Signals Investor Cautio...
  • 5/12/2025EndoCell Secures ~CNY 200M in Dual-Round Financing to Accelerate Cell ...
  • 5/12/2025Regenverse Raises ~CNY 100M in Pre-A Financing to Advance Regenerative...
  • 5/12/2025METiS Eyes US$200M Hong Kong IPO as AI Drug Sector Heats Up
  • 5/12/2025Chinese Pharma Firms Expected to Withstand Trump's Drug Price Crackdow...
  • 5/12/2025Trump's Drug Pricing and the US-China Trade Deal: "Our Interests are D...
  • 5/10/2025~30% of Chinese Listed Pharma Cos Achieve Double Growth in Revenue and...
  • 5/10/2025China's BMI Fund Reports Big Surplus in Q1/2025
  • 5/10/2025Roche Invests Nearly $300M to Build Vabysmo Manufacturing Hub in Shang...
  • 5/10/2025AstraZeneca Launches $475M Small Molecule Drug Plant Project in Wuxi t...
  • 5/10/2025Qilu Secures Greater China Rights to Minghui's B7-H3 ADC in $38M Deal
  • 5/10/2025China's Public Hospitals Grapple with Mounting Debt Amid Reforms and E...
  • Page:6/770 Total number of articles:23098: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group